Protein Biomarker Discovery in Non-depleted Serum by Spectral Library-Based Data-Independent Acquisition Mass Spectrometry.

In discovery proteomics experiments, tandem mass spectrometry and data-dependent acquisition (DDA) are classically used to identify and quantify peptides and proteins through database searching. This strategy suffers from known limitations such as under-sampling and lack of reproducibility of precursor ion selection in complex proteomics samples, leading to somewhat inconsistent analytical results across large datasets. Data-independent acquisition (DIA) based on fragmentation of all the precursors detected in predetermined isolation windows can potentially overcome this limitation. DIA promises reproducible peptide and protein quantification with deeper proteome coverage and fewer missing values than DDA strategies. This approach is particularly attractive in the field of clinical biomarker discovery, where large numbers of samples must be analyzed. Here, we describe a DIA workflow for non-depleted serum analysis including a straightforward approach through which to construct a dedicated spectral library, and indications on how to optimize chromatographic and mass spectrometry analytical methods to produce high-quality DIA data and results.

[1]  Yasset Perez-Riverol,et al.  A multi-center study benchmarks software tools for label-free proteome quantification , 2016, Nature Biotechnology.

[2]  Matthias Mann,et al.  Plasma Proteome Profiling to Assess Human Health and Disease. , 2016, Cell systems.

[3]  Chirag Parikh,et al.  Quantification of Urinary Protein Biomarkers of Autosomal Dominant Polycystic Kidney Disease by Parallel Reaction Monitoring , 2018, Proteomics. Clinical applications.

[4]  Lin Lin,et al.  High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis. , 2018, Journal of proteomics.

[5]  Sabine Bahn,et al.  Proteomic approaches to identify blood-based biomarkers for depression and bipolar disorders , 2018, Expert review of proteomics.

[6]  Ákos Végvári,et al.  Biobank resources for future patient care: developments, principles and concepts , 2011, Journal of Clinical Bioinformatics.

[7]  Ziding Feng,et al.  Quantitative Proteomics Based on Optimized Data-Independent Acquisition in Plasma Analysis. , 2017, Journal of proteome research.

[8]  Dieter Deforce,et al.  Comparison of fractionation proteomics for local SWATH library building , 2017, Proteomics.

[9]  Núria Malats,et al.  Large-Scale SRM Screen of Urothelial Bladder Cancer Candidate Biomarkers in Urine. , 2017, Journal of proteome research.

[10]  Marco Y. Hein,et al.  Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ * , 2014, Molecular & Cellular Proteomics.

[11]  Yuanyue Li,et al.  Group-DIA: analyzing multiple data-independent acquisition mass spectrometry data files , 2015, Nature Methods.

[12]  Oliver M. Bernhardt,et al.  Optimization of Experimental Parameters in Data-Independent Mass Spectrometry Significantly Increases Depth and Reproducibility of Results* , 2017, Molecular & Cellular Proteomics.

[13]  Thomas Burger,et al.  DAPAR & ProStaR: software to perform statistical analyses in quantitative discovery proteomics , 2016, Bioinform..

[14]  Kristin L Cheek,et al.  Depletion of abundant plasma proteins and limitations of plasma proteomics. , 2010, Journal of proteome research.

[15]  N. Anderson,et al.  The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. , 2010, Clinical chemistry.

[16]  Ruedi Aebersold,et al.  DIGESTIF: a universal quality standard for the control of bottom-up proteomics experiments. , 2015, Journal of proteome research.

[17]  Qin Fu,et al.  Preparation of proteins and peptides for mass spectrometry analysis in a bottom-up proteomics workflow. , 2009, Current protocols in molecular biology.

[18]  Roman Fischer,et al.  GOAT – A simple LC-MS/MS gradient optimization tool , 2014, Proteomics.

[19]  Knut Reinert,et al.  Tools for Label-free Peptide Quantification , 2012, Molecular & Cellular Proteomics.

[20]  Oliver M. Bernhardt,et al.  Extending the Limits of Quantitative Proteome Profiling with Data-Independent Acquisition and Application to Acetaminophen-Treated Three-Dimensional Liver Microtissues* , 2015, Molecular & Cellular Proteomics.

[21]  Christoph H. Borchers,et al.  Mass spectrometry based biomarker discovery, verification, and validation — Quality assurance and control of protein biomarker assays , 2014, Molecular oncology.

[22]  Ludovic C. Gillet,et al.  Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps , 2015, Nature Medicine.

[23]  Hanno Steen,et al.  Advancing Urinary Protein Biomarker Discovery by Data-Independent Acquisition on a Quadrupole-Orbitrap Mass Spectrometer. , 2015, Journal of proteome research.

[24]  M. Mann,et al.  Universal sample preparation method for proteome analysis , 2009, Nature Methods.

[25]  Jenny Forshed,et al.  Experimental Design in Clinical 'Omics Biomarker Discovery. , 2017, Journal of proteome research.

[26]  R. Sharan,et al.  Quantitative mass spectrometry analysis reveals a panel of nine proteins as diagnostic markers for colon adenocarcinomas , 2018, Oncotarget.

[27]  E. Bellei,et al.  High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins , 2010, Amino Acids.

[28]  Emmanuelle Plaisier,et al.  Multiplex and accurate quantification of acute kidney injury biomarker candidates in urine using Protein Standard Absolute Quantification (PSAQ) and targeted proteomics. , 2017, Talanta.

[29]  He Wang,et al.  Preliminary study of protein changes in trisomy 21 fetus by proteomics analysis in amniocyte , 2018, Prenatal diagnosis.

[30]  Ben C. Collins,et al.  OpenSWATH enables automated, targeted analysis of data-independent acquisition MS data , 2014, Nature Biotechnology.

[31]  Michael J MacCoss,et al.  Multiplexed peptide analysis using data-independent acquisition and Skyline , 2015, Nature Protocols.

[32]  Karl Mechtler,et al.  Optimized Nonlinear Gradients for Reversed-Phase Liquid Chromatography in Shotgun Proteomics , 2013, Analytical chemistry.

[33]  Tao Liu,et al.  Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer , 2017, Scientific Data.

[34]  Bo Xu,et al.  Proteome Profiling of Diabetic Mellitus Patient Urine for Discovery of Biomarkers by Comprehensive MS-Based Proteomics , 2018, Proteomes.

[35]  Giuseppe Infusini,et al.  Discovery and Validation of Novel Protein Biomarkers in Ovarian Cancer Patient Urine , 2018, Proteomics. Clinical applications.

[36]  Hasmik Keshishian,et al.  Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury* , 2015, Molecular & Cellular Proteomics.

[37]  Ying Zhang,et al.  The Use of Variable Q1 Isolation Windows Improves Selectivity in LC-SWATH-MS Acquisition. , 2015, Journal of proteome research.

[38]  John D. Venable,et al.  Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra , 2004, Nature Methods.

[39]  Matthias Mann,et al.  Region and cell-type resolved quantitative proteomic map of the human heart , 2017, Nature Communications.

[40]  Yimeng Song,et al.  Data‐Independent Acquisition‐Based Quantitative Proteomic Analysis Reveals Potential Biomarkers of Kidney Cancer , 2017, Proteomics. Clinical applications.

[41]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.

[42]  Jonas Grossmann,et al.  Targeted Proteomics Guided by Label-free Quantitative Proteome Analysis in Saliva Reveal Transition Signatures from Health to Periodontal Disease * , 2018, Molecular & Cellular Proteomics.

[43]  Chih-Chiang Tsou,et al.  DIA-Umpire: comprehensive computational framework for data-independent acquisition proteomics , 2015, Nature Methods.